Mon.Jul 04, 2022

article thumbnail

Controlling contamination by material transfer

European Pharmaceutical Review

Ensuring potential microbial contaminants are not transferred into cleanroom environments is a key aspect of risk mitigation strategies. In a review, pharmaceutical microbiologist and contamination control expert Tim Sandle, reviewed several methods of material transfer, listing the decontamination methods based on efficacy and commenting on their weaknesses. .

article thumbnail

GSK acquires US-based Sierra Oncology for $1.9bn

Pharmaceutical Technology

GlaxoSmithKline (GSK) has completed the acquisition of all outstanding shares of US-based Sierra Oncology in a deal totalling $1.9bn (£1.6bn), in cash. In April this year, GSK entered an agreement for the acquisition of Sierra Oncology for $55 per share. The conclusion of the deal comes after the shareholders of Sierra Oncology approved the takeover on 29 June this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: Physician turnover rates are climbing as they clamor for better work-life balance

MedCity News

Job turnover is on the rise among physicians because their desire for flexibility and work-life balance is emboldening them to leave jobs where they feel overworked or underappreciated, according to a new report. It found that 43% of physicians switched jobs during the pandemic, 8% retired, and 3% left medicine to work in a non-clinical career.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on

Pharma 122
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Partners come on board GSK’s plan for Stevenage life science hub

pharmaphorum

GSK’s recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative. The asset management arm of Swiss back UBS has formed a joint venture with property developer Reef Group that will develop the 33-acre campus in Stevenage, Hertfordshire.

article thumbnail

Brii Bio acquires Vir’s antibody rights for Hepatitis B in Greater China

Pharmaceutical Technology

Brii Biosciences (Brii Bio) has exercised an option for the acquisition of exclusive development and marketing rights for Vir Biotechnology’s investigational antibody, VIR-3434, for Hepatitis B in Greater China, under a partnership agreement. Following the option exercise, Vir will receive the option exercise fee, regulatory and commercial milestone payments as well as tiered royalties on net product sales from Brii Bio.

Safety 111

More Trending

article thumbnail

Biotech IPO freeze continues as second quarter is slowest in more than a decade

MedCity News

Summer weather is heating up but the market for IPOs remains cold. Bausch + Lomb’s successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years.

Marketing 104
article thumbnail

StartUp Health takes a multidisciplinary approach to fight type 1 diabetes

pharmaphorum

David Weingard, chief impact officer of T1D Moonshot and founder of Cecelia Health, tells us how T1D Moonshot aims to break silos and advance type 1 diabetes prevention and treatment options by utilising numerous partners’ expertise. In the US alone, 37.3 million Americans live with diabetes, with 1.6 million having type 1 diabetes (T1D). Still, a scarcity of T1D treatments exists.

article thumbnail

Lonza to build €500m fill and finish facility in Stein

European Pharmaceutical Review

Lonza announced that it is investing approximately CHF 500 million (€500m) to build a new flexible fill and finish facility in Stein, Switzerland. The facility will be located on the same campus as Lonza’s clinical drug product facility, allowing the company to leverage existing infrastructure, capabilities and talent. . According to the company, the investment completes the company’s strategic commitment to offer an integrated end-to-end service that includes commercial drug product manufacturi

article thumbnail

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

pharmaphorum

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndrome (SBS), although its share price remains under pressure. Interim results of the VIBRANT study of vurolenatide have identified a suitable dosing regimen for the drug to take forward into phase 3, with preliminary evidence of efficacy and a favourable safety profile, said the North Carolina biotech. 9 Meters

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Advanz finalises acquisition of Intercept operations across Europe and Canada

PharmaTimes

The deal will give Advanz an increased presence in the treatment of rare diseases

101
101
article thumbnail

Omnichannel strategies to revolutionize the healthcare professional experience

pharmaphorum

Two years into the COVID-19 pandemic, engaging with healthcare professionals about treatments has never been more difficult. Consultants, doctors, and nurses are overworked, stressed, and tired. Backlogs in hospitals show no sign of clearing. The old multichannel approach to medical and commercial strategy is no longer as effective as it once was. Simply blitzing doctors and consultants with as much information as possible fails to drive engagement when many healthcare professionals struggle to

article thumbnail

Oxford Biomedica, AstraZeneca enter new deal for Covid-19 vaccine

Pharmaceutical Technology

Oxford Biomedica has entered a new three-year Master Services & Development Agreement to potentially manufacture AstraZeneca UK’s Covid-19 vaccines in the future. The latest deal is an extension of an original Master Supply and Development Agreement signed by the parties in September 2020. Under the initial deal, the production of Covid-19 vaccines at the Oxbox facility of Oxford Biomedica is anticipated to conclude in the last quarter of this year.

article thumbnail

Innovative Trials acquires first US office

PharmaTimes

The development is part of company’s mission to support patient access to clinical trials

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

US pharma industry IT recruitment activity drops 3.0% in June 2022

Pharmaceutical Technology

The US’s pharma industry registered a 3.0% drop in IT hiring activity in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 5.96% in June 2022 when compared with May 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.92% share in June 2022, recording an increase of 0.05% over the last three-month average share.

article thumbnail

Teva poaches Vertex exec as new head of R&D

pharmaphorum

Teva chief executive Kare Schultz has lined up the appointment he wants to revitalise the company’s R&D operations, naming Vertex Pharma’s Eric Hughes to the role of executive vice president of R&D and chief medical officer. Eric A Hughes. Hughes – currently Vertex’s head of clinical development and translational medicine – will make the move to his new employer on 1 August, less than a year after taking on the role.

article thumbnail

AstraZeneca’s IT hiring activity declines 12.3% in June 2022

Pharmaceutical Technology

UK-based company AstraZeneca’s IT hiring declined 12.3% in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 9.51% in June 2022 when compared with May 2022. IT jobs claimed an 8.11% share in the company’s total hiring activity in June 2022, and recorded a 0.16% growth over the last three-month average share.

Leads 52
article thumbnail

UK adds £175m funding to clinical research recovery drive

pharmaphorum

The UK government has made an additional £175 million ($212 million) in funding available for its push to make the country a go-to location for clinical research, adding to £200 million promised in March to strengthen the national data infrastructure. The new money has been announced to coincide with the publication of a new three-year strategic plan aimed at recovering the UK’s capacity to deliver research following the pandemic, increasing national capacity for clinical research, and imp

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Bayer’s IT hiring activity declines 8.0% in June 2022

Pharmaceutical Technology

Germany-based company Bayer’s IT hiring declined 8.0% in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 10.56% in June 2022 when compared with May 2022. IT jobs claimed a 6.24% share in the company’s total hiring activity in June 2022, and recorded a 0.43% growth over the last three-month average share.

Leads 52
article thumbnail

Scanning for Health Indicators and Risks Through Your Smartphone

Impetus Digital

Vlado Bosanac , Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging , sat down with me in this episode of Healthcare Goes Digital. We dived into the implications of increased integration of tech and data into daily life for the digital health industry and personal health outcomes, Advanced Human Imaging’s patented smartphone-based human scanning technology, and much more. .

Doctors 52
article thumbnail

Johnson & Johnson’s IT hiring activity rises 57.2% in June 2022

Pharmaceutical Technology

US-based company Johnson & Johnson’s IT hiring rose 57.2% in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 46.7% in June 2022 when compared with May 2022. IT jobs claimed a 4.3% share in the company’s total hiring activity in June 2022, and recorded a 0.49% growth over the last three-month average share.

Leads 52
article thumbnail

F. Hoffmann-La Roche’s IT hiring activity declines 16.3% in June 2022

Pharmaceutical Technology

Switzerland-based company F. Hoffmann-La Roche’s IT hiring declined 16.3% in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 11.52% in June 2022 when compared with May 2022. IT jobs claimed an 8.21% share in the company’s total hiring activity in June 2022, and recorded a 1.41% decline over the last three-month average share.

Leads 52
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

MerckInc’s IT hiring activity declines 1.2% in June 2022

Pharmaceutical Technology

US-based company MerckInc’s IT hiring declined 1.2% in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 13.1% in June 2022 when compared with May 2022. IT jobs claimed a 5.91% share in the company’s total hiring activity in June 2022, and recorded a 0.71% growth over the last three-month average share.

Leads 52
article thumbnail

Cloud hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for cloud related positions rose in June 2022 compared with the equivalent month last year, with 44.8% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 40.2% of companies who were hiring for cloud related jobs a year ago but a decrease compared to the figure of 47.1% in May 2022.

article thumbnail

Spain’s pharma industry IT recruitment activity drops 25.5% in June 2022

Pharmaceutical Technology

Spain’s pharma industry registered a 25.5% drop in IT hiring activity in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 7.41% in June 2022 when compared with May 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 7.72% share in June 2022, recording a decrease of 3.34% over the last three-month average share.

article thumbnail

UK pharma industry IT recruitment activity drops 4.9% in June 2022

Pharmaceutical Technology

The UK’s pharma industry registered a 4.9% drop in IT hiring activity in June 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 3.02% in June 2022 when compared with May 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 3.85% share in June 2022, recording a decrease of 0.22% over the last three-month average share.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic